Reports

7498 Results (Page 47 of 300)

Pharmaceuticals Markets Research Reports

Pharmaceuticals

Brazil Transdermal Skin Patches Market Analysis

Brazil Transdermal Skin Patches Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Transdermal Skin Patches market is growing globally due to the increasing demand for non-invasive drug delivery, growing prevalence of chronic diseases like cardiovascular disorders, pain management, hormonal imbalances and neurological conditions, geriatric application and pediatric applications of transdermal skin patches due to better patient compliance, advancements in patch technology, expansion of therapeutic applications of transdermal skin patches like hormone replacement therapy, smoking cessation, motion sickness, dermatological conditions, and increasing focus on personalized medicine. Adhex Pharma, ProSolus, Inc, Tapemark, Tesa Tapes Pvt. Ltd., Nitto Denko Corporation, Noven Pharmaceuticals, Inc, LTS Lohmann Therapie-Systeme are the key global market players in transdermal skin patches market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Glutathione Market Analysis

China Glutathione Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased prevalence of chronic diseases, demand in the cosmetics and beauty industry, and sports nutrition and performance enhancement are key drivers of the glutathione market. Kyowa Hakko Bio Co., Shandong Jincheng Biological Pharmaceutical Co., Kohjin Life Sciences, NOW Health Group, Merck KGaA, Kaiping Genuine Biochemical Pharmaceutical Co., Mitsubishi Tanabe Pharma Corporation, Shenzhen GSH Bio-Technology Co., Energetic Nutrition, and TCI Chemicals are the global players in the glutathione market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Ovarian Cancer Drugs Market Analysis

Egypt ovarian cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is anticipated to develop as a result of the rising number of elderly women, rise in ovarian cancer cases, ease of use of new treatments and therapies, and increase in healthcare spending. Government spending is also accelerating the market's expansion. Some of the major key players in this market are F. Hoffmann-La Roche AG, Amgen Inc., Pfizer, Inc., Clovis Oncology, AstraZeneca, Abbvie Inc., etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Germany Alopecia Drugs (Hair Loss) Market Analysis

Germany alopecia drugs (hair loss) market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of alopecia, rising awareness and consciousness among individuals about their appearance, and the development of advanced treatment technologies. Johnson & Johnson, Merck & Co., GlaxoSmithKline plc, Cipla Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Pfizer Inc., Histogen Inc., Aclaris Therapeutics, and Concert Pharmaceuticals are the key players in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Indonesia HER-2 Negative Breast Cancer Market Analysis

Indonesia HER-2 Negative Breast Cancer Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. A number of factors, such as age, obesity, alcoholism, radiation exposure history, family history of breast cancer, family history of the disease, age at first pregnancy, onset of the menstrual cycle, and tobacco use, increase the risk of developing the disease. As a result of lifestyle changes, the incidence and prevalence of breast cancer are rising quickly. All of this will drive a HER-2 Negative Breast Cancer Market.The global HER-2 Negative Breast Cancer market’s major key players are Pfizer, Novartis AG Merck & Co. Inc., GlasxoSmithKline, Eli Lilly and Company, Bristol Myers Squibb Company, AstraZeneca, Lupin, Bayer AG.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Japan Pharmaceutical Excipient Market Analysis

Japan Pharmaceutical Excipient market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Pharmaceutical Excipient is growing rapidly as a result of growing Pharmaceutical Industry, Generic Drug Production driven by patent expiration and cost considerations, drug delivery systems advncements like such as controlled-release formulations, nanoparticles, and transdermal patches, requires specialized excipients to achieve the desired drug release profiles. Kerry Group plc., DFE Pharma, Cargill, Incorporated, Pfanstiehl, Colorcon, MEGGLE GmbH & Co. KG, Omya AG, Peter Greven GmbH & Co. KG, Ashland., Evonik, Dow, Croda International Plc, Roquette Frères., The Lubrizol Corporation, BASF SE, Avantor, Inc., BENEO, Chemie Trade are the key global market players.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Biological Safety Testing Market Analysis

Malaysia Biological safety testing Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The biological safety testing market is driven by increasing demand for biologics, stringent regulatory requirements, rising incidence of infectious diseases, technological advancements, and growth in the biotechnology and pharmaceutical industries. Charles River Laboratories International, Merck KGaA, Lonza Group Ltd., Eurofins Scientific, SGS SA, WuXi AppTec, Toxikon Corporation, Avista Pharma Solutions, Nelson Laboratories, Pace Analytical Services are among the global key players.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Influenza Vaccine Market Analysis

Mexico influenza vaccine market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The government's increased emphasis on and support for the influenza vaccination is one of the major factors influencing the global market. Leading market players like CSL Limited, Sanofi, and GlaxoSmithKline plc are increasing their R&D expenditures in order to enhance their production capabilities and concentrate on the introduction of new vaccines, which is what is causing the industry to continue to grow. GlaxoSmithKline plc (U.K.), Sanofi (France), AstraZeneca (U.K.), CSL Limited (Australia), BIKEN Co., Ltd. (Japan), Abbott (U.S.), Sinovac (China) are the top key players operating in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Philippines Pneumococcal Vaccines Market Analysis

Philippines Pneumococcal Vaccines Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Pneumococcal Vaccines Market is growing due to the increase in the number of people suffering from pneumonia across the globe, rise in demand for specific medication for treating complications associated with the disease such as breathing issues, surge in the financial support to the researchers for developing novel intervention, increase in the introduction of novel pneumococcal vaccines, growing government spending and health-awareness efforts to successfully treat disorder development in technology, surge in healthcare expenditure, growth in population and special designation from the regulatory authority and development in the protein-based vaccines for pneumonia. Sanofi, Panacea Biotec Ltd., Pfizer Inc., Glaxo smith kline, PnuVax Incorporated, SK Bioscience, Walvax Biotechnology Co., Ltd., and Beijing Minhai Biotechnology Co., Ltd. Are the key global market players operating in pneumococcal vaccines market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Singapore Cell Based Immunotherapy Market Analysis

Singapore Cell Based Immunotherapy Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing incidence of cancer, advancements in cell therapy technologies, a favourable regulatory environment, growing investments and collaborations, the trend toward personalised medicine, positive clinical outcomes, and patient demand for effective and targeted treatments are driving the cell-based immunotherapy market. Novartis, Gilead Sciences, Bristol Myers Squibb, bluebird bio, Adaptimmune Therapeutics, Cellectis, and Precision Biosciences are among the leading global players.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Lipid Lowering Drugs Market Analysis

South Africa lipid lowering drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increase in heart disease cases, higher awareness of the health risks associated with high cholesterol levels, and the availability of effective treatments are key factors driving the global market for lipid-lowering pharmaceuticals. The major key players in this market are Sanofi, Sun Pharmaceutical Industries Ltd., AstraZeneca, Pfizer Inc., Novartis AG, AbbVie Inc., Merck & Co. Inc., Amgen Inc., and Dr. Reddy's.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Spain Respiratory Drugs Market Analysis

Spain Respiratory Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Respiratory Drugs market is growing globally due to the rising elderly population, rising respiratory disease prevalence and technological developments in respiratory medications, growing demand for combination therapies due to the rising prevalence of multi-drug-resistant bacteria, and technological advancements in drug delivery devices. The chronic obstructive pulmonary disease (COPD) segment is projected to grow at the highest CAGR during the forecast period owing to the increasing prevalence of COPD across the globe. Allied Healthcare, Cardinal Health, Covidien, Drager Medical, DeVilbiss Healthcare, Fisher & Paykel Healthcare, Getinge, Hamilton Medical, Invacare Corporation, NSpire Health and ResMed are the key global market players in respiratory drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

UK Depression/Major Depressive Disorders (MDD) Market Analysis

UK Depression/Major Depressive Disorders (MDD) Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Factors driving the Depression/Major Depressive Disorders (MDD) market include rising global depression prevalence, increased awareness and understanding of mental health issues, advancements in treatment options such as new medications and therapies, rising healthcare expenditure and insurance coverage for mental health, and government initiatives aimed at improving mental healthcare access. Pfizer Inc., Eli Lilly and Company, Johnson & Johnson, GlaxoSmithKline plc, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Bristol Myers Squibb Company, H. Lundbeck A/S, Merck & Co., Inc., Allergan plc are global key players in Depression/Major Depressive Disorders (MDD) Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

US Microspheres Market Analysis

US microspheres market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Medical science and technology improvements as well as rising usage in the medical business are the main drivers of the market under study. The key players in this market are Nouryon Chemicals Holding B.V., Trelleborg AB, Chase Corporation, Mo SCI Corporation, 3M Co., and Kureha Corporation.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Vietnam T-Cell Lymphoma Market Analysis

Vietnam T-Cell Lymphoma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. T-Cell Lymphoma market is growing globally due to the High lymphoma cancer incidence rate, rising healthcare expenditure, rising number of geriatric population, increasing risk of lymphoma due to autoimmune disorders, high disposable income, advancement in T-cell lymphoma-specific therapies, unmet medical needs, advances in diagnostic techniques and increasing utilization of immunotherapies. Bristol Myers Squibb Company, Novartis AG, Kyowa Kirin Co., Ltd., Merck & Co., Inc., Seattle Genetics, Inc., Spectrum Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Eisai Co., Ltd., BeiGene, Ltd., and Epizyme, Inc. are the key global market players in T-Cell Lymphoma Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Brazil Transthyretin Amyloidosis (ATTR) Market Analysis

Brazil Transthyretin Amyloidosis (ATTR) Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Transthyretin Amyloidosis (ATTR) market is growing globally due to the increase in disease awareness, advancements in diagnostic techniques, development of disease-modifying therapies, growing investment in research and development, regulatory support and expedited approvals, collaboration and partnerships between pharmaceutical companies and academic institutions. Pfizer Inc, AstraZeneca, Prothena Corporation plc, Ionis Pharmaceuticals, BELLUS Health Inc , Alnylam Pharmaceuticals, Inc, Eidos Therapeutics, Inc, SOM BIOTECH, Abbvie, Inc., Bausch Health Companies Inc., Bristol Myers Squibb Company, GSK Plc. are the key global market players in transthyretin amyloidosis (ATTR) market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Gram Positive Bacterial Infections Market Analysis

China Gram Positive Bacterial Infections Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the gram-positive bacterial infections market include the increasing prevalence of these infections, the emergence of antibiotic resistance, technological advancements in diagnostics and treatments, and the growing healthcare infrastructure, leading to higher demand for effective treatments and the need for innovative solutions to combat these infections. Global Players in Gram positive Bacterial Infections market are Pfizer Inc., Merck & Co., GlaxoSmithKline, Novartis AG, Sanofi S.A., Johnson & Johnson Services, AbbVie Inc., Bayer AG, AstraZeneca plc and Eli Lilly and Company.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Pancreatic Cancer Drugs Market Analysis

Egypt pancreatic cancer drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Genetic anomalies including the BRCA2 gene mutation, Lynch syndrome, and familial atypical mole-malignant melanoma (FAMMM) syndrome may increase the risk of cancer running in the family. The dynamics of the market will be impacted by the rising rates of diabetes and obesity, which will raise the risk of pancreatic cancer. Some of the major key players in this market are Eli Lilly and Company, Celgene, Roche, Novartis, Clovis Oncology, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Germany Aminoglycosides Market Analysis

Germany Aminoglycosides Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The Aminoglycosides market is a segment of the pharmaceutical industry that focuses on the production and sale of aminoglycoside antibiotics. Key factors driving the market include the increasing prevalence of bacterial infections, especially drug-resistant strains, which require potent antibiotics like aminoglycosides. The growing geriatric population and the rise in chronic diseases also contribute to the demand for aminoglycosides. The market analysis also considers restraints such as the potential side effects and toxicity associated with aminoglycoside use. These antibiotics can cause serious adverse effects, including kidney damage and hearing loss, which limit their long-term use. Furthermore, the emergence of alternative antibiotics and the growing concern over antibiotic resistance pose challenges to the market growth. Some of the prominent global players in the Aminoglycosides market include Pfizer Inc., Merck & Co., Inc., Novartis AG, Bristol Myers Squibb Company, Eli Lilly and Company, Abbott Laboratories, Johnson & Johnson, Aurobindo Pharma Ltd., Teva Pharmaceutical Industries Ltd., and Mylan N.V.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Indonesia Herceptin Biosimilar Market Analysis

Indonesia herceptin biosimilar market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. The market grows as a result of increased research and development as well as rising public knowledge of cancer treatments. Additionally, rising healthcare costs and the existence of innovative pipeline products create an opportunity for market expansion. Some of the key players in this market are Mylan N.V., Amgen Inc., Mabion S.A., AryoGen Biopharma, Genor Biopharma, Celltrion Inc., Gedeon Richter Plc, The Instituto Vital Brazil, F. Hoffmann-La Roche AG, and Biocon.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Japan Pharmaceutical Filtration Market Analysis

Japan Pharmaceutical Filtration Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Pharmaceutical Filtration is growing rapidly as a result of increase in biopharmaceutical production, factors including the rising demand for high-quality pharmaceutical products, stringent regulatory standards, need to decrease illnesses linked to healthcare, rising demand for ultrafiltration track-etched membranes and increasing usage of single-use technologies. Merck KGaA, Pall Corporation (Danaher Corporation), Sartorius AG, GE Healthcare, 3M Company, Parker Hannifin Corporation, Eaton Corporation, Amazon Filters Ltd., Meissner Filtration Products Inc., Graver Technologies are the key global market players in Pharmaceutical Filtration market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Biosimilar Monoclonal Antibodies Market Analysis

Malaysia Biosimilar Monoclonal Antibodies Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Market drivers for biosimilar monoclonal antibodies include rising demand for low-cost biologics, the increasing frequency of chronic diseases, and the need for more economical biologic therapeutics. Among the key global pharmaceutical companies in the Biosimilar Monoclonal Antibodies Market are Samsung Bioepis Co., Celltrion Inc., Biocon Ltd., Pfizer Inc., Amgen Inc., Novartis AG (Sandoz), Mylan N.V., Boehringer Ingelheim International GmbH, Fresenius Kabi AG, and Teva Pharmaceutical Industries Ltd.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Inhalation Anesthesia Market Analysis

Mexico inhalation anesthesia market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market is expected to grow as a result of rising healthcare R&D spending and recent technological and scientific advancements. The market is anticipated to expand because to the rising demand for shorter hospital stays and more accessibility to healthcare services. Halocarbon Products Corporation, Hikima Pharmaceuticals PLC, Lunan Pharmaceutical Group Co. Ltd., Piramal Enterprises Limited, Jiangsu Hengrui Medicine Co. Ltd., Fresenius Kabi AG, AbbVie Inc are the top key players operating in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Philippines Polycystic Kidney Disease (APDKD) Market Analysis

Philippines Polycystic Kidney Disease (APDKD) Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Polycystic Kidney Disease (APDKD) market is growing globally due to the he ADPKD market has experienced significant growth due to increased awareness, improved diagnostics, and advancements in treatment options. The market size is expected to expand further with the introduction of innovative therapies and the rising incidence of ADPKD. Johnson & Johnson Private Limited, Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., GlaxoSmithKline plc, AbbVie Inc., Novartis AG, Taro Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Ltd., Eli Lilly and Company are the key global market players in polycystic kidney disease (APDKD) market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Singapore Cholesterol / Lipid Lowering Drugs Market Analysis

Singapore Cholesterol / Lipid Lowering Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising global prevalence of cardiovascular diseases, increased awareness about the health risks associated with high cholesterol levels, the ageing population, sedentary lifestyles, unhealthy dietary habits, and the need for effective treatments are some of the key drivers in the cholesterol/lipid lowering drugs market. growth. Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie, Inc., Viatris (Mylan N.V.), AstraZeneca PLC, and Dr. Reddy’s Laboratories Ltd.are global key players in Cholesterol / Lipid Lowering Drugs Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

subscribe to our newsletter
up